Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Buildings (2016 - 2025)

Utah Medical Products has reported Buildings over the past 15 years, most recently at $14.4 million for Q4 2025.

  • Quarterly results put Buildings at $14.4 million for Q4 2025, up 6.25% from a year ago — trailing twelve months through Dec 2025 was $14.4 million (up 6.25% YoY), and the annual figure for FY2025 was $14.4 million, up 6.25%.
  • Buildings for Q4 2025 was $14.4 million at Utah Medical Products, up from $13.5 million in the prior quarter.
  • Over the last five years, Buildings for UTMD hit a ceiling of $14.4 million in Q4 2025 and a floor of $13.5 million in Q4 2024.
  • Median Buildings over the past 5 years was $13.9 million (2023), compared with a mean of $13.9 million.
  • Biggest five-year swings in Buildings: fell 4.03% in 2022 and later increased 6.25% in 2025.
  • Utah Medical Products' Buildings stood at $14.2 million in 2021, then dropped by 4.03% to $13.6 million in 2022, then grew by 2.25% to $13.9 million in 2023, then fell by 2.65% to $13.5 million in 2024, then increased by 6.25% to $14.4 million in 2025.
  • The last three reported values for Buildings were $14.4 million (Q4 2025), $13.5 million (Q4 2024), and $13.9 million (Q4 2023) per Business Quant data.